MALAT1 and COVID-19: MALAT1 lncRNA has recently been discovered to have a significant part in an expanding spectrum of illnesses and their progressions, including diabetes and its related complications [36, 37], inflammatory disorders such as Coronavirus disease 2019 (COVID-19) [38, 39], and sepsis, in addition to its well-known function in the progression of cancers [40, 41].